Journal of labelled compounds and radiopharmaceuticals p. 229 - 235 (2006)
Update date:2022-08-03
Topics:
Oba, Makoto
Ohkuma, Kosuke
Hitokawa, Hiroshi
Shirai, Ayumi
Nishiyama, Kozaburo
Novel 3,4-didehydropyroglutamate derivatives, the key intermediates in this synthesis, were obtained from a protected pyroglutamate by the well-known selenenylation-oxidative deselenenylation method and were catalytically deuterated using a slow-addition technique. The obtained deuterated pyroglutamates were converted to [3,4-2H2]glutamic acid, [3,4,5-2H3]proline, and [3,4,5,5,5-2H 5]leucine via an appropriate functional group interconversions followed by the standard deprotection procedure. Copyright
View MoreHangzhou Hysen Pharma co.,Ltd.
website:http://www.hysenpharma.cn/
Contact:0086-571-88298791
Address:#701,Gudun Road Hangzhou
Xian Changyue Biological Technology Co., Ltd.
website:https://www.xachangyue.com/
Contact:+86-029-62886900
Address:Keji Road NO.70
Zhejiang Quzhou Jiancheng Silicone Co., Ltd.(Shanghai Jiancheng Industial and Trade Co, Ltd)
Contact:18957018777 +86-570-3888777
Address:The company production base address: Quzhou City, Zhejiang Province high-tech industrial park Nianhua Road 37
Zhejiang Hoshine Silicon Industry Co., Ltd.
Contact:86-573-89179966
Address:Zhapu Town, Pinghu City, Zhejiang, China
Contact:0086-22-2822 1962 / 2822 1963
Address:B-808, No. 1, North-South Street, Hexi District,
Doi:10.1002/anie.200600666
(2006)Doi:10.1016/j.electacta.2006.05.023
(2006)Doi:10.1007/BF00579470
(1984)Doi:10.1016/S0040-4039(01)80212-4
(1984)Doi:10.1021/ja064737l
(2006)Doi:10.1016/j.bmc.2007.08.046
(2007)